London-based ExSeed Health secures €2.9 million for its male fertility testing kit

Published on February 15, 2022

Pioneering male fertility startup ExSeed Health has just picked up a €2.9 million seed extension round, led by Ascension and with participation from Trifork, Hambro Perks, and R42 Group. The investment comes after ExSeed has maintained average month-on-month sales growth rates of more than 20% in 2021. Founded in 2017, ExSeed is breaking the taboo…

This content is for members only. Visit the site and log in/register to read.

The post London-based ExSeed Health secures €2.9 million for its male fertility testing kit appeared first on EU-Startups.